FUREN Group Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares FUREN Group Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Shenzhen Salubris Pharmaceuticals Co Ltd
sales of 2.74 billion Chinese Renmimbi [US$425.43 million]
of which 98%
was Pharmaceutical Manufacturing),
Mayinglong Pharmaceutical Group Co Ltd
(2.79 billion Chinese Renmimbi [US$433.67 million]
of which 53%
was Pharmaceutical Industry), and
Hengkang Medical Group Co Ltd
(2.79 billion Chinese Renmimbi [US$433.71 million]
FUREN Group Pharmaceutical Co Ltd reported sales of 2.84 billion Chinese Renmimbi (US$441.93 million)
December of 2020.
decrease of 45.0%
versus 2019, when the company's sales were 5.17 billion Chinese Renmimbi.